Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 97

1.

Controlled ovarian hyperstimulation pharmacogenetics: a simplified model to genetically dissect estrogen-related diseases.

Morón FJ, Galán JJ, Ruiz A.

Pharmacogenomics. 2007 Jul;8(7):775-85.

PMID:
17638514
[PubMed - indexed for MEDLINE]
2.

Genetic profile of SNP(s) and ovulation induction.

Loutradis D, Theofanakis Ch, Anagnostou E, Mavrogianni D, Partsinevelos GA.

Curr Pharm Biotechnol. 2012 Mar;13(3):417-25.

PMID:
21657995
[PubMed - indexed for MEDLINE]
3.

Pharmacogenetics of controlled ovarian hyperstimulation.

de Castro F, Morón FJ, Montoro L, Real LM, Ruiz A.

Pharmacogenomics. 2005 Sep;6(6):629-37. Review.

PMID:
16143002
[PubMed - indexed for MEDLINE]
4.

Pharmacogenetics of follicle-stimulating hormone action.

Laan M, Grigorova M, Huhtaniemi IT.

Curr Opin Endocrinol Diabetes Obes. 2012 Jun;19(3):220-7. doi: 10.1097/MED.0b013e3283534b11. Review.

PMID:
22499219
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Follicle-stimulating hormone receptor polymorphism (Thr307Ala) is associated with variable ovarian response and ovarian hyperstimulation syndrome in Indian women.

Achrekar SK, Modi DN, Desai SK, Mangoli VS, Mangoli RV, Mahale SD.

Fertil Steril. 2009 Feb;91(2):432-9. doi: 10.1016/j.fertnstert.2007.11.093. Epub 2008 Mar 5.

PMID:
18321487
[PubMed - indexed for MEDLINE]
6.

Ovarian hyperstimulation syndrome (OHSS) due to mutations in the follicle-stimulating hormone receptor.

Rodien P, Beau I, Vasseur C.

Ann Endocrinol (Paris). 2010 May;71(3):206-9. doi: 10.1016/j.ando.2010.02.019. Epub 2010 Apr 2.

PMID:
20362966
[PubMed - indexed for MEDLINE]
7.

Genetic predictors of controlled ovarian hyperstimulation: where do we stand today?

Altmäe S, Hovatta O, Stavreus-Evers A, Salumets A.

Hum Reprod Update. 2011 Nov-Dec;17(6):813-28. doi: 10.1093/humupd/dmr034. Epub 2011 Aug 23. Review.

PMID:
21862569
[PubMed - indexed for MEDLINE]
Free Article
8.

Pharmacogenetics of controlled ovarian hyperstimulation: time to corroborate the clinical utility of FSH receptor genetic markers.

Morón FJ, Ruiz A.

Pharmacogenomics. 2010 Nov;11(11):1613-8. doi: 10.2217/pgs.10.156. Review.

PMID:
21121812
[PubMed - indexed for MEDLINE]
9.

Improved controlled ovarian hyperstimulation in poor responder in vitro fertilization patients with a microdose follicle-stimulating hormone flare, growth hormone protocol.

Schoolcraft W, Schlenker T, Gee M, Stevens J, Wagley L.

Fertil Steril. 1997 Jan;67(1):93-7.

PMID:
8986690
[PubMed - indexed for MEDLINE]
10.

Bone morphogenetic protein 15 (BMP15) alleles predict over-response to recombinant follicle stimulation hormone and iatrogenic ovarian hyperstimulation syndrome (OHSS).

Morón FJ, de Castro F, Royo JL, Montoro L, Mira E, Sáez ME, Real LM, González A, Mañes S, Ruiz A.

Pharmacogenet Genomics. 2006 Jul;16(7):485-95.

PMID:
16788381
[PubMed - indexed for MEDLINE]
11.

Advanced reproductive age and fertility.

Reproductive Endocrinology and Infertility Committee; Family Physicians Advisory Committee; Maternal-Fetal Medicine Committee; Executive and Council of the Society of Obstetricians, Liu K, Case A.

J Obstet Gynaecol Can. 2011 Nov;33(11):1165-75.

PMID:
22082792
[PubMed - indexed for MEDLINE]
13.

Molecular pathology of the FSH receptor: new insights into FSH physiology.

Meduri G, Bachelot A, Cocca MP, Vasseur C, Rodien P, Kuttenn F, Touraine P, Misrahi M.

Mol Cell Endocrinol. 2008 Jan 30;282(1-2):130-42. doi: 10.1016/j.mce.2007.11.027. Epub 2007 Dec 4. Review.

PMID:
18248882
[PubMed - indexed for MEDLINE]
14.

Review of available infertility treatments.

Hrometz SL, Gates VA.

Drugs Today (Barc). 2009 Apr;45(4):275-91. doi: 10.1358/dot.2009.45.4.1360985. Review.

PMID:
19499093
[PubMed - indexed for MEDLINE]
15.

Pharmacogenetics in ovarian stimulation--current concepts.

Loutradis D, Vlismas A, Drakakis P, Antsaklis A.

Ann N Y Acad Sci. 2008 Apr;1127:10-9. doi: 10.1196/annals.1434.001. Review.

PMID:
18443324
[PubMed - indexed for MEDLINE]
16.

Thrombophilia and ovarian hyperstimulation syndrome: a case report.

Levy G, Lucidi RS.

Hawaii Med J. 2011 May;70(5):97-8.

PMID:
21857739
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Use of the aromatase inhibitor letrozole for ovulation induction in women with polycystic ovarian syndrome.

Casper RF, Mitwally MF.

Clin Obstet Gynecol. 2011 Dec;54(4):685-95. doi: 10.1097/GRF.0b013e3182353d0f.

PMID:
22031258
[PubMed - indexed for MEDLINE]
18.

Effects of gonadotropin-releasing hormone antagonists on the expression of vascular endothelial growth factor and its receptors in a rat model of ovarian hyperstimulation syndrome.

Tong XM, Zhang SY, Song T, Xu WH, Lin XN, Shu J, Liu L.

Chin Med J (Engl). 2008 Dec 5;121(23):2434-9.

PMID:
19102964
[PubMed - indexed for MEDLINE]
19.

The addition of GnRH antagonists in intrauterine insemination cycles with mild ovarian hyperstimulation does not increase live birth rates--a randomized, double-blinded, placebo-controlled trial.

Cantineau AE, Cohlen BJ, Klip H, Heineman MJ; Dutch IUI Study Group Collaborators.

Hum Reprod. 2011 May;26(5):1104-11. doi: 10.1093/humrep/der033. Epub 2011 Feb 20.

PMID:
21339196
[PubMed - indexed for MEDLINE]
Free Article
20.

Predicting and preventing ovarian hyperstimulation syndrome (OHSS): the need for individualized not standardized treatment.

Fiedler K, Ezcurra D.

Reprod Biol Endocrinol. 2012 Apr 24;10:32. doi: 10.1186/1477-7827-10-32. Review.

PMID:
22531097
[PubMed - indexed for MEDLINE]
Free PMC Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk